Is Genpact Ltd. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 14, an EV to EBITDA of 10.29, and a Price to Book Value of 3.09. In comparison to peers, ICON plc has a P/E of 14.64, while Booz Allen Hamilton Holding Corp. stands at 15.81, suggesting that Genpact is competitively priced within its industry.
Despite its fair valuation, Genpact has underperformed relative to the S&P 500, with a year-to-date return of -8.17% compared to the index's 13.30%. This trend continues over longer periods, with a 3-year return of -12.78% versus 81.19% for the S&P 500, highlighting potential concerns regarding its growth prospects.